Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Opiant Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 35 | 42 | +7 |
| Shares | 1.27M | 1.42M | +146.4K (+11.5%) |
| Value | $32.7M | $47.6M | +$14.9M (+45.7%) |
New holders (11)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DLD Asset Management, LP | 30,000 | $1.01M | 0.09% |
| Marshall Wace, LLP | 23,577 | $793.0K | 0.00% |
| State Street Corp | 12,000 | $404.0K | 0.00% |
| Bank of New York Mellon Corp | 7,803 | $262.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 6,417 | $216.0K | 0.00% |
| Hillsdale Investment Management Inc. | 3,200 | $108.0K | 0.01% |
| Dorsey Wright & Associates | 2,138 | $72.0K | 0.01% |
| TAP Consulting, LLC | 471 | $16.0K | 0.00% |
| CoreCap Advisors, LLC | 266 | $9.00K | 0.00% |
| Retirement Planning Co of New England, Inc. | 180 | $6.00K | 0.00% |
| National Bank of Canada | 100 | $3.00K | 0.00% |
Sold out (4)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Rothschild & Co Wealth Management UK Ltd | 1,419 | $37.0K |
| ClariVest Asset Management LLC | 366 | $9.00K |
| Tower Research Capital LLC (TRC) | 138 | $4.00K |
| O'Shaughnessy Asset Management, LLC | 41 | $1.00K |